Kenneth J. Fasola - Dec 2, 2021 Form 4 Insider Report for MAGELLAN HEALTH INC (MGLN)

Role
Chief Executive Officer, Director
Signature
/s/ Kenneth J. Fasola
Stock symbol
MGLN
Transactions as of
Dec 2, 2021
Transactions value $
-$319,437
Form type
4
Date filed
12/6/2021, 04:13 PM
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGLN Ordinary Common Stock, $0.01 par value Options Exercise $0 +8.58K +71.88% $0.00 20.5K Dec 2, 2021 Direct F1, F2
transaction MGLN Ordinary Common Stock, $0.01 par value Tax liability -$319K -3.38K -16.45% $94.62 17.1K Dec 2, 2021 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGLN Restricted Stock Units Options Exercise $0 +8.58K $0.00 8.58K Dec 2, 2021 Common Stock 8.58K $0.00 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on December 2, 2019. Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock.
F2 Not applicable.
F3 Represents the portion of shares withheld by the Company in order to pay taxes.
F4 Closing price on NASDAQ on December 2, 2021.
F5 The remainder of 8,580 Restricted Stock Units shall vest on December 2, 2022, subject to earlier acceleration or forfeiture.